Development of new nanomaterials that inhibit or kill bacteria is an important and timely research topic. For example, financial losses due to infectious iseases, such as diarrhea, are a major concern in livestock productions around the world. Antimicrobial nanoparticles represent a promising alternative to antibiotics and may lower antibiotic use and consequently spread of antibiotic resistance traits among bacteria, including pathogens.